FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor ImmunityVikas Duhan, Rajiv Khanna, Ma. Ricci Gomez et al.|Cancer Immunology Research|2025Cited by 0
Data from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor ImmunityVikas Duhan, Rajiv Khanna, Ma. Ricci Gomez et al.|Unknown|2025Cited by 0
Supplementary Figure S1 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor ImmunityVikas Duhan, Rajiv Khanna, Ma. Ricci Gomez et al.|Unknown|2025Cited by 0
Supplementary Figure S3 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor ImmunityVikas Duhan, Rajiv Khanna, Greg Kelly et al.|Unknown|2025Cited by 0
Supplementary Figure S2 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor ImmunityVikas Duhan, Rajiv Khanna, Thuy T. Le et al.|Unknown|2025Cited by 0